Koyfin Home > Directory > Health Care > Acorda Therapeutics > Net Debt / (EBITDA-CAPEX)

Acorda Therapeutics Net Debt / (EBITDA-CAPEX) Chart (ACOR)

Acorda Therapeutics annual/quarterly Net Debt / (EBITDA-CAPEX) from 2010 to 2020.
  • Acorda Therapeutics Net Debt / (EBITDA-CAPEX) for the quarter ending June 06, 2020 was $-4m a 76.63% decrease of -3m year over year
  • Acorda Therapeutics Net Debt / (EBITDA-CAPEX) for the last 12 months ending June 06, 2020 was $-2m a 63.92% decrease of -1m year over year
  • Acorda Therapeutics Annual Net Debt / (EBITDA-CAPEX) for 2019 was $-1m a -82.15% increase of 1m from 2018
  • Acorda Therapeutics Annual Net Debt / (EBITDA-CAPEX) for 2018 was $-1m a 116.32% decrease of -2m from 2017
  • Acorda Therapeutics Annual Net Debt / (EBITDA-CAPEX) for 2017 was $0m a -13,278.15% decrease of -31m from 2016
Other Ratios Metrics:
  • Acorda Therapeutics Total Debt / Capital for the quarter ending December 12, 2018 was $36m a -5.79% decrease of -2m year over year
  • Acorda Therapeutics Other Liabilities for the quarter ending December 12, 2018 was $204m a 10.59% increase of 22m year over year
  • Acorda Therapeutics Total Debt / Equity for the quarter ending December 12, 2018 was $56m a -9.35% decrease of -5m year over year
View Chart On Koyfin

Quarterly ACOR Net Debt / (EBITDA-CAPEX) Data

06/2020$-4m
03/2020$-2m
12/2019$-2m
09/2019$-1m
06/2019$0m
03/2019$0m
12/2018$1m
09/2018$-1m
06/2018$0m
03/2018$0m

Annual ACOR Net Debt / (EBITDA-CAPEX) Data

2019$-1m
2018$-1m
2017$0m
2016$31m
2015$-1m
2014$0m
2013$-8m
2012$-11m
2011$-6m
2010$34m